Publications by authors named "Matt Kalaycio"

Claim this Profile
I
Infections in steroid-refractory chronic graft versus host disease patients treated with ruxolitinib, ibrutinib, or belumosudil.
Victoria Stepanyants, Hong Li, Danielle Cenin, Jessi Edwards, Claudio Brunstein, Matt Kalaycio

Bone Marrow Transplant· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myeloablative and Reduced Intensity Allogeneic Transplant in Patients with Myeloproliferative Neoplasms.
Andrew D Trunk, Yanwen Chen, Aaron T Gerds, Akriti Jain, Sudipto Mukherjee, Matt Kalaycio

Hematol Oncol Stem Cell Ther· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Obesity on GVHD in Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Hematologic Malignancies.
Valentina Ardila, Hong Li, Claudio Brunstein, Matt Kalaycio, Ronald Sobecks

Transplant Cell Ther· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clonal hematopoiesis-derived therapy-related myeloid neoplasms after autologous hematopoietic stem cell transplant for lymphoid and non-lymphoid disorders.
Hussein Awada, Carmelo Gurnari, Valeria Visconte, Arda Durmaz, Teodora Kuzmanovic, Matt Kalaycio

Leukemia· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What do atomic bomb survivors teach us about therapy-free remission in people with chronic myeloid leukaemia?
Tomas Radivoyevitch, Robert Peter Gale, Matt E Kalaycio

Leukemia· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tacrolimus/methotrexate vs tacrolimus/reduced-dose methotrexate/mycophenolate for graft-versus-host disease prevention.
Betty K Hamilton, Lisa A Rybicki, Hong Li, Taylor Lucas, Donna Corrigan, Matt Kalaycio

Blood Adv· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between the choice of the conditioning regimen and outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis.
Guru Subramanian Guru Murthy, Soyoung Kim, Noel Estrada-Merly, Muhammad Bilal Abid, Mahmoud Aljurf, Matt Kalaycio

Haematologica· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Pilot Trial of Patient-Reported Outcomes for Acute Graft-Versus-Host-Disease.
Sagar S Patel, Sanghee Hong, Lisa Rybicki, Stephanie Farlow, Jane Dabney, Matt Kalaycio

Transplant Cell Ther· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of the role of corrected DLCO in predicting outcomes post autologous hematopoietic cell transplant for multiple myeloma.
Hussein Awada, Adel Hajj Ali, Muhammad Faizan Ali, Craig Sauter, Betty Hamilton, Matt Kalaycio

Eur J Haematol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resource utilization in patients with large B-cell lymphoma receiving tisagenlecleucel and axicabtagene ciloleucel.
Agrima Mian, Wei Wei, Betty K Hamilton, Allison M Winter, Jack Khouri, Matt Kalaycio

Bone Marrow Transplant· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pattern of somatic mutation changes after allogeneic hematopoietic cell transplantation for acute myeloid leukemia and myelodysplastic syndromes.
Sanghee Hong, Lisa Rybicki, Carmelo Gurnari, Simona Pagliuca, Aiwen Zhang, Matt Kalaycio

Bone Marrow Transplant· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of pre-transplant risk assessments in allogeneic hematopoietic cell transplant.
Pranay S Hegde, Lisa Rybicki, Sheila Serafino, Laura Bernhard, Donna Corrigan, Matt Kalaycio

Bone Marrow Transplant· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toxicity analysis of busulfan pharmacokinetic therapeutic dose monitoring.
Kelly J Gaffney, Theresa A Urban, Mariana Lucena, Faiz Anwer, Robert M Dean, Matt E Kalaycio

J Oncol Pharm Pract· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Quality of Life and Outcomes between Haploidentical and Matched Related/Unrelated Donor Allogeneic Hematopoietic Cell Transplantation.
Sanghee Hong, Lisa Rybicki, Linda Mclellan, Jane Dabney, Aaron T Gerds, Matt Kalaycio

Transplant Cell Ther· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of Allogeneic Hematopoietic Cell Transplantation in T Cell Prolymphocytic Leukemia: A Contemporary Analysis from the Center for International Blood and Marrow Transplant Research.
Hemant S Murthy, Kwang Woo Ahn, Noel Estrada-Merly, Hassan B Alkhateeb, Susan Bal, Matt Kalaycio

Transplant Cell Ther· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relapse and Disease-Free Survival in Patients With Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation Using Older Matched Sibling Donors vs Younger Matched Unrelated Donors.
Guru Subramanian Guru Murthy, Soyoung Kim, Zhen-Huan Hu, Noel Estrada-Merly, Muhammad Bilal Abid, Matt Kalaycio

JAMA Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of socioeconomic disparities on the use of upfront autologous stem cell transplantation for mantle cell lymphoma.
Yazeed Sawalha, Tomas Radivoyevitch, Xuefei Jia, Katherine Tullio, Robert M Dean, Matt Kalaycio

Leuk Lymphoma· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Day 100 risk assessment tool predicts overall survival in allogeneic hematopoietic cell transplantation.
Pranay Hegde, Lisa Rybicki, Sheila Serafino, Christina Ferraro, Matt Kalaycio

Bone Marrow Transplant· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival following relapse after allogeneic hematopoietic cell transplantation for acute leukemia and myelodysplastic syndromes in the contemporary era.
Sanghee Hong, Lisa Rybicki, Donna Corrigan, Betty K Hamilton, Ronald Sobecks, Matt Kalaycio

Hematol Oncol Stem Cell Ther· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of Killer Immunoglobulin-Like Receptors and Somatic Mutations on Transplant Outcomes in Acute Myeloid Leukemia.
Sanghee Hong, Lisa Rybicki, Aiwen Zhang, Dawn Thomas, Cassandra M Kerr, Matt Kalaycio

Transplant Cell Ther· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fludarabine and Melphalan Compared with Reduced Doses of Busulfan and Fludarabine Improve Transplantation Outcomes in Older Patients with Myelodysplastic Syndromes.
Betül Oran, Kwang Woo Ahn, Caitrin Fretham, Amer Beitinjaneh, Asad Bashey, Matt Kalaycio

Transplant Cell Ther· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase II Trial of Imatinib Mesylate as Maintenance Therapy for Patients With Newly Diagnosed C-kit-positive Acute Myeloid Leukemia.
Anjali S Advani, William Tse, Hong Li, Xuefei Jia, Paul Elson, Matt Kalaycio

Clin Lymphoma Myeloma Leuk· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DNA methylation inhibition in myeloma: Experience from a phase 1b study of low-dose continuous azacitidine in combination with lenalidomide and low-dose dexamethasone in relapsed or refractory multiple myeloma.
Jack Khouri, Beth M Faiman, Dale Grabowski, Reda Z Mahfouz, Shahper N Khan, Matt Kalaycio

Semin Hematol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Personalized Prediction Model for Outcomes after Allogeneic Hematopoietic Cell Transplant in Patients with Myelodysplastic Syndromes.
Aziz Nazha, Zhen-Huan Hu, Tao Wang, R Coleman Lindsley, Hisham Abdel-Azim, Matt Kalaycio

Biol Blood Marrow Transplant· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality-of-Life Trajectories in Adolescent and Young Adult versus Older Adult Allogeneic Hematopoietic Cell Transplantation Recipients.
Reema R Mathanda, Betty K Hamilton, Lisa Rybicki, Anjali S Advani, Amy Colver, Matt Kalaycio

Biol Blood Marrow Transplant· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis